EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Recalcitrant Diabetic Macular Edema Case Report despite Anti-Vascular Endothelial Growth Factor Therapy during Pregnancy

Lena Nour Juratli, Claire Deng, Yannis M Paulus

Case Reports in Ophthalmology · 26.08.2026 · 17 (1) · 998-1005

DOI: 10.1159/cop/acaag010 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Case Reports in Ophthalmology, online erschienen am 26.08.2026. Verfasst von Lena Nour Juratli und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NEI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Anti-vascular endothelial growth factor (anti-VEGF) therapy is often the first-line treatment for diabetic macular edema (DME), but during pregnancy, focal laser photocoagulation is often preferred. We aim to report a case of anti-VEGF use during pregnancy for DME. Case Presentation: A 37-year-old pregnant female with a history of insulin-dependent, poorly controlled diabetes mellitus and proliferative diabetic retinopathy with macular edema presented with decreased vision. She had previously undergone focal laser therapy, but due to the appearance of symptomatic scotomas, had declined further focal laser treatment. Despite receiving intravitreal bevacizumab (IVB) injections, the patient’s DME worsened during pregnancy. The patient had subsequent fetal loss and recurrent macular edema in both eyes after delivery.

Conclusion

This report presents a severe case of DME that was recalcitrant to treatment with anti-VEGF treatment during pregnancy. The fetal loss is likely attributable to underlying medical conditions, including poorly controlled diabetes, hypertension, and congestive heart failure exacerbations requiring hospitalizations, rather than IVB. This case highlights the need for a multidisciplinary approach in pregnancy that combines optimized glycemic control and localized ocular therapy.

Schlagwörter

Stichwörter der Autor:innen

Anti-vascular endothelial growth factorBevacizumabCase reportDiabetic macular edemaDiabetic retinopathyPregnancy

Autor:innen und Institutionen

  • Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA.
  • Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA.
  • Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA.

Förderung

  • NEI NIH HHS

Zitieren

APA

Juratli, L. N., Deng, C., & Paulus, Y. M. (2026). Recalcitrant Diabetic Macular Edema Case Report despite Anti-Vascular Endothelial Growth Factor Therapy during Pregnancy. Case Reports in Ophthalmology, 17(1), 998-1005. https://doi.org/10.1159/cop/acaag010

Vancouver

Juratli LN, Deng C, Paulus YM. Recalcitrant Diabetic Macular Edema Case Report despite Anti-Vascular Endothelial Growth Factor Therapy during Pregnancy. Case Reports in Ophthalmology. 2026;17(1):998-1005. doi:10.1159/cop/acaag010

BibTeX
@article{Juratli2026,
  author = {Juratli, Lena Nour and Deng, Claire and Paulus, Yannis M},
  title = {Recalcitrant Diabetic Macular Edema Case Report despite Anti-Vascular Endothelial Growth Factor Therapy during Pregnancy},
  journal = {Case Reports in Ophthalmology},
  year = {2026},
  volume = {17},
  number = {1},
  pages = {998--1005},
  doi = {10.1159/cop/acaag010}
}
Kostenlos starten →